Ann: AnteoTech Developing Multiplex Test for COVID-19, page-84

I enjoyed the reference to Ellume - just a nod to shareholders confirming we are involved.

Analytical Sensitivity of Rapid Diagnostic Tests

AnteoTech has developed several approaches to rapid diagnostic testing1. Rapid tests have generally been applied to tests for which “yes/no” results are sufficient. The results can be read by eye (eg pregnancy test). AnteoBind activated IMRA Gold nanoparticles are used in the development of such tests. For tests that require greater sensitivity, Europium nanoparticle based detection can provide up to 20 times improvement 2. These fluorescent tests require a reader such as the Axxin AX-2X-S Lateral Flow Reader to provide the result1. AnteoBind can enable the production of quantum dot fluorescent particles, as are used in Ellume tests, or activated Europium particles, as have been used in the recently announced AnteoTech multiplex sepsis panel1.